Researchers have identified a biochemical pathway in cancer stem cells which are essential for the development of head and neck cancers.
A new study has discovered the distribution of white matter abnormalities found in some patients with mTBI closely resemble those seen in early Alzheimer’s disease.
Researchers have discovered a new virus, CyCV-VN, in patients with severe brain infections. However, doctors have not yet found the cause of the infection, despite extensive diagnostic efforts. Currently, there are no treatment interventions for this virus.
Researchers show memory pathology in older mice can be reversed by blocking the activity of a specific receptor in the brain. Blocking the B1R receptor helps recover memory and cerebrovascular function.
Researchers have discovered a neural pathway in which the brain controls a specific molecule, connected to bipolar disorder and schizophrenia which is also critical to the formation of long term memory.
Researchers have developed an experimental drug, NitroMemantine, to boost brain synapses lost in Alzheimer’s disease. The drug stops the destructive cascade of brain changes which destroy connections between neurons that leads to memory loss and cognitive decline.
Researchers have discovered Mannitol, a sugar alcohol commonly found in sugar-free gum and candy, prevents clumps of the protein α-synuclein from building in the brain. This build of this protein is characteristic of Parkinson’s disease. The finding could provide potential treatment options for this and other neurodegenerative diseases.
A new study uncovers unique changes in DNA structure in genes important to neuronal function in relatives with early onset, familial Alzheimer’s disease.
According to a new study, specific MicroRNA naturally packaged into exosomes are released by stem cells after a stroke, contributing to better neurological recovery.